Lanxin Hu

Publication Activity (10 Years)

Years Active: 2022-2023
Publications (10 Years): 2

Top Topics

Ischemia Reperfusion Injury

Oxide Nanoparticles

Systematic Review

Epithelial Mesenchymal Transition

Top Venues

Journal of oncology

Clinical and experimental medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Hao Zeng, Chengyuan Zhou, Xiaojing Chen, Lanxin Hu, Shansha Cheng, Lu Guo, Yunwei Han
Comparison of the efficacy and safety of selective internal radiotherapy and sorafenib alone or combined for hepatocellular carcinoma: a systematic review and Bayesian network meta-analysis. Clinical and experimental medicine (2023)
Xiaojing Chen, Lanxin Hu, Xinrui Mao, Haoran Chen, Yuchen She, Hao Chi, Hao Zeng, Lu Guo, Yunwei Han
Upregulated LINC00922 Promotes Epithelial-Mesenchymal Transition and Indicates a Dismal Prognosis in Gastric Cancer. Journal of oncology 2022 (2022)